FEATURE ARTICLES

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin

Allowing Compounding Pharmacies to Address Drug Shortages

The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss after Intracranial Hemorrhage: A Case Report

APPLIED COMPOUNDING

Quality Control: Photodocumentation in Pharmacy Compounding

Compounding Nonsterile Preparations Using Cyclodextrins

Methods of Sterilization and Depyrogenation

PEER REVIEW

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)

Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate

Molding as Innovative Technology for Personalized Tablet Production

DEPARTMENTS

Prescription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" (January 2018)

Calculations

Index of Advertisers

FORMULATIONS
Alprazolam 1 mg/mL in SyrSpend SF PH4 Oral Suspension
Codeine Phosphate 3 mg/mL in Ora-Sweet
Ketoconazole 2%, Terbinafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Lorazepam 1 mg/mL in SyrSpend SF PH4
Mesalamine 100 mg/mL Suspension Enema
Naproxen 25 mg/mL in SyrSpend SF PH4
Phenobarbital 10 mg/mL in SyrSpend SF PH4 Cherry Flavored
Phenytoin 15 mg/mL in SyrSpend SF PH4
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend Suspension
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF PH4

Get a free digital sample, search 25 years of content, and subscribe today to IJPC - The only journal solely dedicated to the art and science of pharmaceutical compounding!